The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 21, 2018
Filed:
Mar. 22, 2016
Applicant:
Evestra, Inc., San Antonio, TX (US);
Inventors:
Hareesh Nair, San Antonio, TX (US);
Bindu Santhamma, San Antonio, TX (US);
Klaus Nickisch, Berlin, DE;
Assignee:
Evestra, Inc., Schertz, TX (US);
Primary Examiner:
Int. Cl.
CPC ...
C07J 1/00 (2006.01); C07J 11/00 (2006.01); C07J 31/00 (2006.01); C07J 41/00 (2006.01); C07J 43/00 (2006.01); C07J 21/00 (2006.01); C07J 51/00 (2006.01); C07J 71/00 (2006.01);
U.S. Cl.
CPC ...
C07J 1/0096 (2013.01); C07J 11/00 (2013.01); C07J 31/006 (2013.01); C07J 41/0083 (2013.01); C07J 43/003 (2013.01); C07J 21/006 (2013.01); C07J 51/00 (2013.01); C07J 71/001 (2013.01);
Abstract
Described herein are new anti-cancer compounds and methods of using such compounds, acting through a new mechanism of action by simultaneous inhibition of leukemia inhibitory factor (LIF) and MDM2.
Quick Actions:
Nair, Hareesh. (2018). Cytotoxic agents that preferentially target leukemia inhibitory factor (lif) for the treatment of malignancies and as new contraceptive agents (U.S. Patent No. 10053485). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/10053485
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile